Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of ...

Their use in a range of other indications, such as gastrointestinal and head and neck cancer, is currently under investigation. The number of agents included in this drug group is increasing ...

Thirdly, iatrogenic alterations in gastrointestinal and/or liver physiology can alter the pharmacokinetics and pharmacodynamics of oral targeted agents, which differ in their properties from ...